Triple-negative breast carcinoma (TNBC), is an aggressive molecular subgroup of breast cancer characterized by the absence of estrogen receptor alpha/progesterone receptor (ERα/PR) expression and HER2 (ER/PR/HER2-negative) [1]. Here, ERBB2 is linked to breast carcinoma.